Intravenous alteplase for ischaemic stroke

[1] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150

[2] Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients [J]. STROKE, 2005, 36 (11) : 2421 - 2425

[3] Generalized efficacy of t-PA for acute stroke - Subgroup analysis of the NINDS t-PA stroke trial [J]. STROKE, 1997, 28 (11) : 2119 - 2125

[4] Asymptomatic hemorrhage after thrombolysis may not be benign - Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry [J]. STROKE, 2007, 38 (01) : 75 - 79

[5] Thrombolysis in stroke patients aged 80 years and older:: Swiss survey of IV thrombolysis [J]. NEUROLOGY, 2005, 65 (11) : 1795 - 1798

[6] Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort [J]. STROKE, 1999, 30 (11) : 2280 - 2284

[7] Hacke W, 2004, LANCET, V363, P768

[8] Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) : 1307 - 1312

[9] Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1151 - 1158

[10] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1581 - 1587

[1] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150

[2] Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients [J]. STROKE, 2005, 36 (11) : 2421 - 2425

[3] Generalized efficacy of t-PA for acute stroke - Subgroup analysis of the NINDS t-PA stroke trial [J]. STROKE, 1997, 28 (11) : 2119 - 2125

[4] Asymptomatic hemorrhage after thrombolysis may not be benign - Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry [J]. STROKE, 2007, 38 (01) : 75 - 79

[5] Thrombolysis in stroke patients aged 80 years and older:: Swiss survey of IV thrombolysis [J]. NEUROLOGY, 2005, 65 (11) : 1795 - 1798

[6] Hemorrhagic transformation within 36 hours of a cerebral infarct - Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort [J]. STROKE, 1999, 30 (11) : 2280 - 2284

[7] Hacke W, 2004, LANCET, V363, P768

[8] Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) : 1307 - 1312

[9] Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1151 - 1158

[10] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1581 - 1587